Disease severity in children and adults with Pompe disease related to age and disease duration
- 28 June 2005
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 64 (12) , 2139-2141
- https://doi.org/10.1212/01.wnl.0000165979.46537.56
Abstract
Information about 255 children and adults with Pompe disease was gathered through a questionnaire. Disease severity was associated with disease duration and not with age; an early manifestation of the disease implied earlier wheelchair or ventilator dependency. The patient group under age 15 included a subgroup with a more severe and rapid course of the disease. They require more intensive follow-up and early intervention, before irreversible damage has occurred.Keywords
This publication has 9 references indexed in Scilit:
- Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patientsBrain, 2005
- Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: results of a phase II clinical trialNeuromuscular Disorders, 2005
- Late-onset Pompe disease primarily affects quality of life in physical health domainsNeurology, 2004
- Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human α-Glucosidase From MilkPediatrics, 2004
- Enzyme replacement therapy in late‐onset Pompe's disease: A three‐year follow‐upAnnals of Neurology, 2004
- Identification of two subtypes of infantile acid maltase deficiencyThe Journal of Pediatrics, 2000
- Recombinant human α-glucosidase from rabbit milk in Pompe patientsThe Lancet, 2000
- Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counsellingEuropean Journal of Human Genetics, 1999
- Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the diseaseAmerican Journal of Medical Genetics, 1998